[摘要]目的：观察硝苯地平辅助治疗对妊娠高血压患者凝血酶与心功能的影响

[Abstract] Objective: To observe the effects on nifedipine auxiliary thrombin and cardiac function in patients with pregnancy-induced hypertension treatment. Method: The hospital 2017 - September 2019 treated 112 patients with gestational hypertension were divided into groups with reference to the combination group, each of the 56 cases, given with reference to Labeiluoer treatment group, the combination group in order to Rabe plus nifedipine treatment based on lol. Thrombin index before and after treatment groups [prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen (Fib)], cardiac function [troponin (cTnT), plasma brain natriuretic ] varying levels of peptide (BNP). Results: Before treatment, the above-described two groups showed no significant differences in levels are (P> 0.05), after treatment, both groups PT, APPT were significantly increased (P <0.05), the combination group [PT (12.36 ± 0.56) s, APPT (28.02 ± 1.14) s] was significantly higher than the reference group [PT (11.53 ± 0.51) s, APPT (26.33 ± 1.25) s], t = 8.200,7.475, all P <0.05; two Fib, cTnT, BNP levels compared significantly decreased (P <0.05) before treatment, the combination group [Fib (3.05 ± 0.21) g / L, cTnT (0.006 ± 0.002) ng / mL, BNP (183.24 ± 23.47) pg / mL] was significantly lower Referring to the group [Fib (3.92 ± 0.25) s, cTnT (0.007 ± 0.003) ng / mL, BNP (235.21 ± 25.14) pg / mL], t = 19.940,2.076,11.308, all P <0.05. Conclusion: Nifedipine adjuvant therapy for patients with significant coagulation and cardiac function improved high blood pregnancy, there is a certain clinical application value.

Objective: To observe the effect of nitrobenzene-assisted therapy on clotting enzyme and heart function in patients with high blood pressure in pregnancy. Methods: The 112 patients admitted to the hospital from May 2017 to September 2019 were divided into reference group and joint group, each 56 cases, given the reference group Laberol treatment, the joint group on the basis of the use of nitrobenzene leveling treatment on the basis of Laberol. Comparing the two groups of clotting enzyme indicators before and after treatment ( ceagulase time (PT), activated part of the clotting enzyme time (APTT), fibrinogen (Fib) ) , cardiac function indicators ( serum troponin ( cTnT), plasma brain sodium peptide (BNP) ) . Results: Before treatment, there was no significant difference in the level of the two groups of the above-mentioned indicators, both (P.0.05), after treatment, the average increase of PT and APPT water in both groups (average P 0.05), the joint group (PT (12.36 x 0.56), APPT (28.02 x 1.14)s) significantly higher than the reference group (PT (11.53 0 s) .51) s, APPT (26.33 x 1.25)s), t-8.200, 7.475, average P 0.05; two groups of Fib, cTnT, BNP water average significantly lower than before treatment (average P 0.05), joint group (Fib (3.05 x 0.21)g/L , cTnT (0.006 x 0.002) ng/mL, BNP (183.24 x 23.47) pg/mL " significantly lower than the reference group (Fib (3.92 x 0.25) s, cTnT (0 .007 to 0.003) ng/mL, BNP (235.21 x 25.14) pg/mL), t-19.940, 2.076, 11.308, all P.05. Conclusion: Nitrobenzene assisted therapy has significant clinical application value to improve the blood clotting function and heart function of high blood patients in pregnancy.

[Abstract] Objective: To observe the effect of nifedipine on thrombin and cardiac function in patients with pregnancy induced hypertension. Methods: 112 patients with gestational hypertension admitted in our hospital from May 2017 to September 2019 were divided into the reference group and the combined group, 56 cases in each group, and were given rabeprolol treatment in the reference group, and nifedipine treatment in the combined group on the basis of rabeprolol. The levels of prothrombin time (PT), APTT, FIB, cTnT and BNP were compared before and after treatment. Results: before treatment, there was no significant difference between the two groups (P > 0.05). After treatment, the levels of Pt and appt in the two groups were significantly increased (P < 0.05). The levels of [Pt (12.36 ± 0.56) s, appt (28.02 ± 1.14) s] in the combined group were significantly higher than those in the reference group [Pt (11.53 ± 0.51) s, appt (26.33 ± 1.25) s], t = 8.200, 7.475, all P < 0.05; the levels of FIB, cTnT and BNP in the two groups were significantly higher than those in the control group Before treatment, the levels of [FIB (3.05 ± 0.21) g / L, cTnT (0.006 ± 0.002) ng / ml, BNP (183.24 ± 23.47) pg / ml] in the combined group were significantly lower than those in the reference group [FIB (3.92 ± 0.25) s, cTnT (0.007 ± 0.003) ng / ml, BNP (235.21 ± 25.14) pg / ml], t = 19.940, 2.076, 11.308, all P < 0.05. Conclusion: nifedipine can improve the coagulation and heart function of patients with high blood pressure in pregnancy, which has a certain clinical value.<br>